Brain Advance Access originally published online on October 6, 2004
Brain 2004 127(11):2518-2532; doi:10.1093/brain/awh273
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain Vol. 127 No. 11 © Guarantors of Brain 2004; all rights reserved
Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues
1 Centro Dino Ferrari, Dipartimento di Scienze Neurologiche, Università degli Studi di Milano, IRCCS Ospedale Maggiore Policlinico, Milano, 2 Centro di Eccellenza per lo Studio delle Malattie Neurodegenerative, Università degli Studi di Milano, Milano and 3 IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy
Correspondence to: Professor Giacomo P. Comi, Dipartimento di Scienze Neurologiche, Università di Milano, Padiglione Ponti, Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy E-mail: giacomo.comi{at}unimi.it
Amyotrophic lateral sclerosis (ALS) is a progressive, lethal neurodegenerative disease without any effective therapy. To evaluate the potential of wild-type bone marrow (BM)-derived stem cells to modify the ALS phenotype, we generated BM chimeric Cu/Zn superoxide dismutase (SOD1) mice by transplantation of BM cells derived from mice expressing green fluorescent protein (GFP) in all tissues and from Thy1-YFP mice that express a spectral variant of GFP (yellow fluorescent protein) in neurons only. In the recipient cerebral cortex, we observed rare GFP+ and YFP+ neurons, which were probably generated by cell fusion, as demonstrated by fluorescence in situ hybridization (FISH) analysis, suggesting that this phenomenon is not limited to Purkinje cells. GFP-positive microglial cells were extensively present in both the brain and spinal cord of the affected animals. Completely differentiated and immature GFP+ myofibres were also present in the heart and skeletal muscles of SOD1 mice, confirming that BM cells can participate in striated muscle tissue regeneration. Moreover, wild-type BM chimeric SOD1 mice showed a significantly delayed disease onset and an increased life span, probably due to a positive ‘non-neuronal environmental’ effect rather than to neuronogenesis. This improvement in SOD1-G93A mouse survival is comparable with that previously obtained using some safer pharmacological agents. BM transplantation-related complications in humans preclude its clinical application for ALS treatment. However, our data suggest that further studies aimed at improving the degree of tissue chimerism by BM-derived cells may provide valuable insights into strategies to slow ALS progression.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. H. Appel, J. I. Engelhardt, J. S. Henkel, L. Siklos, D. R. Beers, A. A. Yen, E. P. Simpson, Y. Luo, G. Carrum, H. E. Heslop, et al. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis Neurology, October 21, 2008; 71(17): 1326 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kaneko, K. M. Nishiguchi, M. Nakamura, S. Kachi, and H. Terasaki Characteristics of Bone Marrow-Derived Microglia in the Normal and Injured Retina Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4162 - 4168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sasahara, A. Otani, A. Oishi, H. Kojima, Y. Yodoi, T. Kameda, H. Nakamura, and N. Yoshimura Activation of Bone Marrow-Derived Microglia Promotes Photoreceptor Survival in Inherited Retinal Degeneration Am. J. Pathol., June 1, 2008; 172(6): 1693 - 1703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Arrell, N. J. Niederlander, R. S. Faustino, A. Behfar, and A. Terzic Cardioinductive Network Guiding Stem Cell Differentiation Revealed by Proteomic Cartography of Tumor Necrosis Factor {alpha}-Primed Endodermal Secretome Stem Cells, February 1, 2008; 26(2): 387 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kang and S. Rivest MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis J. Cell Biol., December 17, 2007; 179(6): 1219 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H.A. Wong, K. N. Lowes, I. Bertoncello, A. F. Quigley, P. J. Simmons, M. J. Cook, A. J. Kornberg, and R. M.I. Kapsa Evaluation of Sca-1 and c-Kit As Selective Markers for Muscle Remodelling by Nonhemopoietic Bone Marrow Cells Stem Cells, June 1, 2007; 25(6): 1364 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Corti, F. Locatelli, D. Papadimitriou, R. Del Bo, M. Nizzardo, M. Nardini, C. Donadoni, S. Salani, F. Fortunato, S. Strazzer, et al. Neural stem cells LewisX + CXCR4 + modify disease progression in an amyotrophic lateral sclerosis model Brain, May 1, 2007; 130(5): 1289 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Beers, J. S. Henkel, Q. Xiao, W. Zhao, J. Wang, A. A. Yen, L. Siklos, S. R. McKercher, and S. H. Appel Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis PNAS, October 24, 2006; 103(43): 16021 - 16026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Corti, F. Locatelli, D. Papadimitriou, C. Donadoni, R. Del Bo, M. Crimi, A. Bordoni, F. Fortunato, S. Strazzer, G. Menozzi, et al. Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1 Hum. Mol. Genet., January 15, 2006; 15(2): 167 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Leri, J. Kajstura, and P. Anversa Cardiac Stem Cells and Mechanisms of Myocardial Regeneration Physiol Rev, October 1, 2005; 85(4): 1373 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kucia, R. Reca, K. Miekus, J. Wanzeck, W. Wojakowski, A. Janowska-Wieczorek, J. Ratajczak, and M. Z. Ratajczak Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF-1-CXCR4 Axis Stem Cells, August 1, 2005; 23(7): 879 - 894. [Abstract] [Full Text] [PDF]
|
|